Dapagliflozin vs Rituximab

## Dapagliflozin vs Rituximab: Overview

This comparison examines the pharmacological differences between **Dapagliflozin** and **Rituximab**.

## Mechanism of Action

**Dapagliflozin**: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Dapagliflozin — 12.9 hours; Rituximab — 22 days.

## Chemical Properties

**Molecular Formula**: Dapagliflozin — C21H25ClO6; Rituximab — N/A.

**Molecular Weight**: Dapagliflozin — 408.8730 g/mol; Rituximab — N/A.

**Type**: Dapagliflozin — Small molecule; Rituximab — Antibody.